PharmaShots | Incisive News in 3 Shots

Subscribe Now

PR

AbbVie Announces FDA's Acceptance of sNDA for PR for Imbruvica (ibrutinib) + Gazyva (Obinutuzumab)

AbbVie Announces FDA's Acceptance of sNDA for PR for Imbruvica (ibrutinib) + Gazyva (Obinutuzumab)

October 17, 2018

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us